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Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the patient, administra-
tive, and legal consequences will be different if the subject is a regular or an occasional cannabis smoker. To this end,
11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) has been proposed as a criterion to help to distinguish between these
two groups of users. However, to date this indicator has not been adequately assessed under experimental conditions. We carried
out a controlled administration study of smoked cannabis with a placebo. Cannabinoid levels were determined in whole blood
using tandemmass spectrometry. Signiﬁcantly high differences in THCCOOH concentrations were found between the two groups
when measured during the screening visit, prior to the smoking session, and throughout the day of the experiment. Receiver
operating characteristic (ROC) curves were determined and two threshold criteria were proposed in order to distinguish between
these groups: a free THCCOOH concentration below 3μg/L suggested an occasional consumption (≤ 1 joint/week) while a
concentration higher than 40μg/L corresponded to a heavy use (≥ 10 joints/month). These thresholds were tested and found
to be consistent with previously published experimental data. The decision threshold of 40μg/L could be a cut-off for possible
disqualiﬁcation for driving while under the inﬂuence of cannabis. A furthermedical assessment and follow-upwould be necessary
for the reissuing of a driving license once abstinence from cannabis has beendemonstrated. A THCCOOH level below 3μg/Lwould
indicate that no medical assessment is required.
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Introduction
Cannabis is the most widely used illegal drug in Switzerland and
in the western world. According to Addiction Monitoring
Switzerland 2012,[1] 5.1% of the Swiss population aged 15 or older
has used cannabis at least once during the last 12months (7.5%
of men, 2.8% of women). The ﬁrst nationwide study on driving
while under the inﬂuence of drugs in Switzerland conﬁrmed that
the most frequently encountered drugs in whole blood (WB)
were cannabinoids (48% of total number of cases).[2] Δ9-
tetrahydrocannabinol (THC), together with its inactive metabolite
11-nor-9-carboxy-THC (THCCOOH), was frequently detected in
the blood of impaired drivers arrested for careless driving or
involved in road accidents.[3,4] Accurate measurement and
interpretation of cannabinoid concentrations can contribute to
the reconstruction of the accident scene, determining the time
lapse between the last cannabis use and the accident and the
assessment of driving impairment level. In this regard, the ability
to drive can be affected in the short term, long term, or perma-
nently. The ﬁtness to drive (long term) can be inﬂuenced by
many parameters. One of them is frequency of cannabis use.
Several recent studies suggest that, compared to occasional
users, regular smokers experience the typical desired and adverse
effects of cannabis less intensely. In the few controlled adminis-
tration studies carried out so far with heavy cannabis smokers,[5,6]
blunted acute psychological and psychomotor disturbances
have been reported. Therefore, the development of a speciﬁc test
and criterion to distinguish regular cannabis use (≥ 10 joints per
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month) from occasional consumption (≤ 1 joint per week) is re-
quired to perform relevant driving ability evaluations. The
suspicion of chronic consumption triggers a cascade of heavy
and expensive administrative measures, but also of toxicological
investigations to conﬁrm a long-term alteration of the ﬁtness to
drive. If the assumption of regular cannabis use is refuted, the
driver could reclaim his conﬁscated driving licence. The subject’s
medical history combined with a medical examination is only of
limited use in detecting chronic cannabis use. In general, it is
preferable to rely on objective data. Regular consumption can
be assessed by measuring drug concentrations in hair. However,
this matrix is not always available, or can be contaminated by
cannabis smoke,[7] or by contact with contaminated body parts
(e.g. urine contaminated dirty hands) and materials, which makes
the interpretation of analytical results difﬁcult. Furthermore, in
comparative studies, discrepancies have been found between
‘positive’ urine specimens and hair tested as ‘negative’[8,9] More
recently, Han et al. failed to detect a signiﬁcant correlation
between self-reported doses and frequency of use and low, me-
dium, and high hair THCCOOH concentration range groups.[10,11]
If hair analysis is of limited value in estimating the frequency of
cannabis consumption, it is, however, widely used in the context
of abstinence control. Thus, the measurement of cannabinoids in
blood offers another strategy to assess the frequency of cannabis
use. In this context, Daldrup et al.[12] have suggested that if the
serum concentration of THCCOOH is lower than 5μg/L the
consumption is assumed to be occasional, while levels above
75μg/L are associated with regular use. This criterion could be
applied in routine forensic examinations on the condition that
serum samples are taken within an eight-day period following
the last cannabis use.[9] Assuming that the smoker would have
stopped smoking during the eight days prior to blood sampling,
the concentration of THCCOOH at the relevant time should be
doubled to 150μg/L. In 2008, Toennes et al.[13] compared the
pharmacokinetic properties of the three main cannabinoids in
occasional and heavy cannabis users. They reported much higher
concentrations in the serum collected from heavy users than
from occasional smokers. These authors also indicated that the
concentration ranges for these two consumer groups greatly
overlapped. In 2013, the French Society of Analytical Toxicology
(SFTA) advocated the use of hair analysis to discriminate between
occasional and regular cannabis use.[14] On the other hand, the
SFTA recommended a cut-off of 50 ng/mL of THCCOOH WB for
the inferior limit, over which a regular consumption of cannabis
(1 joint/day, each day, or more) could be strongly suspected. In
this study, we report on THCCOOH concentrations measured in
797 WB specimens collected during a placebo-controlled
smoking administration study of cannabis in which heavy and
occasional subjects were enrolled. WB samples were collected
during the screening visit, before and after smoking a joint or a
placebo, and up to 3.5 h after the ﬁrst puff. THCCOOH levels in
WB were determined by gas chromatography (GC) or liquid
chromatography (LC) combined with tandem mass spectrometry
(MS/MS).
The purpose of this study is to show that signiﬁcant differences
between these two populations of smokers exist. The second goal
is to propose two THCCOOH threshold concentrations to help deter-
mine whether they are occasional or regular cannabis consumers.
Materials and methods
Study design
The overall design of the study that included various clinical, neu-
roimaging, and psychomotor investigations has been described
in a previous publication and its supporting information.[15] The
imaging sessions determined the timeframe of the one-day
experiment. The study was extended to include a similar-sized
group of young male heavy cannabis smokers. Twenty-three
heavy smokers and 25 occasional smokers, between 18 and
30 years of age, participated in this study. For the occasional
smokers, the mean consumption of cannabis during the three
months preceding inclusion in the study was set at a minimum
of one joint per month and a maximum of one joint per week.
It was set at a minimum of ten joints per month and less than
three joints per day for the heavy users. Heavy smokers who were
multi-daily users (> 3 joints/day) were excluded from the study
because they were unlikely to remain drug-free during the
experimental day, mostly after placebo smoking. Main socio-
demographic characteristics and habits of cannabis consumption
reported by the volunteers are presented in Table 1. Consumption
of any illegal drug other than cannabis was an exclusion criterion
from the study. Subjects recruited for the study participated in
two independent cross-over experimental sessions in which they
smoked either a joint of pure cannabis (0.7 g Bedrobinol, 11%
THC, < 1% CBD, purchased from Bedrocan, Veendam, the
Netherlands) or a placebo (0.8g Santhica variety, no THC, < 0.1%
CBD, provided by the French National Federation of Hemp
Growers, FNPC, Le Mans, France). The ﬁxed-paced smoking proce-
dure consisted of 3 s of preparation, 2 s of inhalation, 5 s of breath
holding and 50 s of exhalation and rest. This sequence was
repeated until two-thirds of the joint was consumed, up to a line
drawn 3 cm above the cardboard ﬁlter. The residue was weighed
to estimate the smoked dose.[15] The investigation period began
Table 1. Sociodemographic characteristics and self-rated patterns of cannabis use in occasional and heavy smokers
Number Mean SD Median Maximum Minimum
Occasional smokers
Age 23.9 3.0 24 29 19
Age at ﬁrst cannabis use 16.3 2.9 16 23 9
Frequency of use (occasions/month, last three months) 3.5 2.3 3.5 10 1
Driving license 22/25 (88 %)
Heavy smokers
Age 22.7 2.4 22 28 19
Age at ﬁrst cannabis use 16.3 2.3 16 20 12
Frequency of use (occasions/month, last three months) 77.9 51.7 62.5 250 20
Driving license 14/23 (61 %)
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in the late morning (11 a.m.) and ended in the evening when the
symptoms of intoxication were almost imperceptible (up to
9p.m.). The volunteers were kept under close watch throughout
the day of the experiment. Blood samples were collected several
hours (5h) and a few minutes before smoking the joint (t =0h) (C0)
and at 0.2, 0.3, 0.4, 0.65, 1.9, 2.5, and 3.5 h after inhalation.
Samples were immediately frozen and kept at -80°C before
analysis. For time schedule reasons, the last blood sample was
omitted for the occasional smokers.
This study was conducted in accordance with good clinical
practices and was approved by the Cantonal Research Ethics
Committee (Vaud). The subjects gave written informed consent
and received ﬁnancial compensation for their participation.
Materials
THC, THCCOOH, and corresponding internal standards (THC-d3
and THCCOOH-d9) were obtained from Cerilliant Corporation
(Round Rock, TX, USA). Triﬂuoroacetic anhydride (TFAA) and
hexaﬂuoro-2-propanol (HFIP) were purchased from Supelco
(Bellefonte, PA, USA) and Fluka (Buchs, Switzerland), respectively.
Hexane, acetonitrile and ethyl acetate were of high-performance
chromatographic grade from Merck (Darmstadt, Germany).
Methods
Analyses of the occasional smokers’ blood specimens were
carried out according to the procedure described by Thomas
et al.[16] Five hundred μL of WB were extracted using a
liquid-liquid extraction (LLE) with hexane: ethyl acetate (9:1,
v/v) and then derivatized with a mixture of TFAA and HFIP
as ﬂuorinated agents. The analysis by MS was performed in
the selected reaction-monitoring mode with a Varian 1200 L
MS/MS triple quadrupole instrument after negative-ion
chemical ionization. The limits of quantiﬁcation (LOQ) of
the method were 0.5 μg/L and 2.5 μg/L for THC and
THCCOOH, respectively.
The same extraction procedure was used for the blood samples
of the heavy smokers, but the analysis was carried out by LC-MS/
MS without a derivatization step. The ion transitions, MS parame-
ters and LC-MS/MS equipment were the same as those described
in a previously published procedure for oral ﬂuid.[17] The
recommendations of the French Society of Pharmaceuticals
Sciences and Techniques (SFSTP) were followed to validate this
LC-MS/MS method. Linearity of this method was from 0.5 to
20μg/L and from 2.5 to 100μg/L for THC and THCCOOH, respec-
tively. Four quality control specimens (QC) (0.5, 1, 10, 20μg/L for
THC and 2.5, 10, 50, 100μg/L for THCCOOH) were analyzed four
times on the same day and on three non-consecutive days to
determine the trueness and precision parameters.[16] The trueness
results ranged between 86% and 113%. The coefﬁcients of
variation (CV) of intra-day and intermediate precisions were lower
than 15% in all cases. Intraday precision results ranged between
3.5 and 11% for THC and between 5.8 and 9.8% for THCCOOH.
Intermediate precision values ranged between 3.8 and 9.8% and
3.9 and 13.8% for THC and THCCOOH, respectively. LOQ values
were determined at the lower QC with a trueness higher than
85% and CVs lower than 20%. LOQs were 0.5 and 2.5μg/L for
THC and THCCOOH, respectively. To facilitate the reading of the
results, concentrations lower than the LOQ were reported as zero.
To cross-validate GC-MS/MS and LC-MS/MS methods, the same
QC were analyzed. No signiﬁcant difference was observed
between these methods. Furthermore, ten authentic blood
specimens were analyzed with both methods yielding almost
identical results.
Statistical analysis
Data, receiver operating characteristics (ROC) curves, box and
whisker graphs were processed and plotted using Excel 2007
and GraphPad Prism 6.02 softwares. True positives (TP) were
correctly identiﬁed smokers, i.e. heavy smokers with THCCOOH
concentrations higher than the threshold. False positives (FP)
were incorrectly identiﬁed heavy smokers, i.e. occasional smokers
with THCCOOH concentrations higher than the threshold. True
negatives (TN) were correctly rejected consumers, i.e. occasional
smokers with THCCOOH concentrations lower than the threshold.
False negatives (FN) were incorrectly rejected users, i.e. heavy
smokers with THCCOOH levels lower than the threshold.
Sensitivity was the proportion of true positives in heavy smokers
who presented sample values exceeding the threshold and was
calculated as TP / TP + FN. Speciﬁcity was estimated by the ratio:
TN / TN+ FP. The positive likelihood ratio (LR+) was calculated as
follows: sensitivity divided by 1 – speciﬁcity.[18,19] The ROC curve
is a graphical plot of true positive rate (sensitivity) versus false
positive rate (1-speciﬁcity) for each THCCOOH threshold. The
maximum speciﬁcity cut-off to rule in the heavy users was set
close to the lower left corner of the ROC curve while the maxi-
mum sensitivity cut-off to rule out the heavy smokers was set
close to the upper right corner.
Results
Sociodemographic characteristics of the volunteers
The two groups of young men were very similar: 25 were
occasional smokers and 23 were heavy cannabis users. Their
mean age were almost the same (23.9 and 22.7, respectively).
Surprisingly, they had the same age of ﬁrst cannabis use (16.3),
but they differed in their frequency of consumption (3.5 and
77.9 occasions per month for occasional and heavy smokers,
respectively). A higher proportion of occasional consumers had
a valid driving license (88 versus 61%).
Kinetic proﬁles of THC and THCCOOH
Figure 1 shows the median time proﬁles of THC and THCCOOH
for the heavy and occasional smokers, before and after smoking
a cannabis joint. These consumers presented similar proﬁles with
parallel kinetic curves. When considering each curve separately,
the inter-quartile range indicates a broad but relatively constant
dispersion of THCCOOH values throughout the experiment
timeframe. Median C0 were 2.1 (range 0.8 to 7.1) and 0 (0–1.4)
μg/L for THC and 20 (2.5–51) and 0 (0–17) μg/L for THCCOOH
for the heavy and occasional cannabis users, respectively. This
latter difference of about 20μg/L between the two THCCOOH
C0 levels remained more or less constant throughout the
experience: for example, median THCCOOH concentrations
measured 2.5 h after smoking the joint were 26 (9.4–78) and 7.1
(0–29) μg/L for the heavy and occasional smokers respectively.
Cannabinoid levels were also determined before and after
smoking the placebo joint (results not shown). The median THC
levels remained lower than 2μg/L throughout the experiment,
while THCCOOH concentrations in the heavy smokers were
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almost all signiﬁcantly higher than the LOQ value. The median
THCCOOH concentrations in the heavy smokers decreased slowly
from 17 (4.3–48) to 10 (0–32) μg/L between 5 h before and 3 h
after smoking the placebo joint. The corresponding C0 median
level was 12 (2.9–38) μg/L. THC could not be quantiﬁed in
any sample of occasional users after smoking the placebo.
THCCOOH was detected in only 14 samples out of 393, i.e. the
median value at each time point remains 0 during the placebo
experimental session.
Concentration differences for THCCOOH between occasional
and regular cannabis smokers
The results for THCCOOH levels are presented as box and whisker
plots in Figure 2. Statistical comparisons (Mann–Whitney test)
were made between the occasional and heavy smokers at each
time point. The heavy smokers’ THCCOOH concentrations were
also compared to the Cmax values of the occasional smokers.
Median (range) THCCOOH concentrations determined at
inclusion were 24 (4.6–70) and 0 (0–< 2.5) μg/L for the heavy
and occasional smokers, respectively. This difference between
groups was highly signiﬁcant (p< 0.0001). The highest THCCOOH
concentration for the occasional smokers was below the LOQ
value while the lowest concentration for the heavy smokers
was 4.6μg/L. Similar results were obtained for THCCOOH levels
just before smoking the placebo or the cannabis joint: the
median THCCOOH C0 were 12 and 20μg/L for the heavy smokers
and 0 and 0μg/L for the occasional smokers, respectively. As
described in the previous paragraph, THCCOOH concentrations
measured 2.5 h after inhalation of the cannabis joint were 26
and 7.1μg/L for the heavy and occasional smokers respectively.
These values were also signiﬁcantly different (p< 0.0001).
Likewise, the difference between the THCCOOH Cmax of the
two groups was signiﬁcant, with median values of 41 and
13μg/L for heavy and occasional smokers, respectively. However,
THCCOOH Cmax determined in the blood of the occasional
cannabis users were not signiﬁcantly different from those
measured in the heavy smokers’ group before smoking the
cannabis or the placebo joint. When we made the same compar-
ison with the ranges of values measured at inclusion and at the
end of the day of the experiment, signiﬁcant differences were
noticed between the heavy and occasional smokers (p< 0.0017
and <0.0023).
ROC curves before inhalation and after smoking
In the ROC curves shown in Figure 3, the true positive rate
(Sensitivity) is plotted as a function of the false positive rate
(100-Speciﬁcity) for different cut-off points of the THCCOOH
concentration. Each point on the ROC curve represents a
sensitivity/speciﬁcity pair corresponding to a particular decision
threshold. The main contribution of the ROC graph is to ﬁnd
out which THCCOOH concentration is the best decision threshold
for differentiating occasional smokers from heavy users. Figure 3a
and 3b present the ROC curves obtained with THCCOOH
concentrations at t = 0, at t = 2.5 h while Figure 3c displays the
compilation of all time data, including those of the smoking
session with placebo. The ROC curves of other sampling times
are also calculated and show the same trends as those measured
before smoking and at the end of the experiment (results not
shown). The group of occasional smokers was selected as the
control group while the heavy smokers were considered as the
group being studied. The area under the ROC curve is a measure
of how well a parameter can distinguish between the two groups
of cannabis users (occasional/heavy). Areas of the ROC curves
calculated for each sampling time are very similar, ranging from
0.90 to 0.96, and thus can be considered as very informative.[19]
The same conclusion can be drawn from the compilation of all
the time points (area equal to 0.88). Before inhalation, a
sensitivity of 100 % (i.e. including all the heavy users) was
obtained for a THCCOOH concentration higher than 2.3μg/L. A
THCCOOH level higher than 18.3μg/L was associated with a
Figure 1. Median THC and median (interquartile) THCCOOH time proﬁles in whole blood of occasional and heavy users before and after smoking a
cannabis joint.
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speciﬁcity of 100 % (i.e. excluding all the occasional smokers). At
t = 2.5 h, these cut-offs were 8.6μg/L and 29.5μg/L for a
sensitivity and a speciﬁcity of 100%, respectively. The two best
decision thresholds (points 1 and 2, empty circles) were
determined using the ROC curve that compiles all THCCOOH
concentrations. Point 1 (lower left corner; 40μg/L) corresponds
to the threshold with a speciﬁcity of 100% that is associated with
the greatest sensitivity. This threshold (> 40μg/L) is used to rule
in the heavy smokers. Point 2 (towards the upper right corner;
3μg/L) is the threshold value that shows the closest sensitivity
to 100% that is associated with the highest speciﬁcity.
This threshold is used to rule out the heavy smokers.
To validate and conﬁrm the choice of these two decision
thresholds, their diagnostic characteristics were calculated and
compared to those of other alternative cut-offs found on both
sides of these values. Table 2 lists the sensitivity and speciﬁcity
values with associated LR +obtained from the compilation of all
time data. THCCOOH blood concentrations and corresponding
serum values are also reported. This latter parameter was
estimated from the THCCOOH serum/WB concentrations ratios
determined by Giroud et al. (1.7)[20] and corroborated by
Karschner et al. (1.8).[21] Table 2 indicates that the two selected
cut-offs represent a good comprise between likelihood ratio,
speciﬁcity, and sensitivity.
The THCCOOH threshold of 3.0μg/L was correlated with a
speciﬁcity of 62 % (LR + of 2.6) and a sensitivity of 97%. The same
parameters for a cut-off greater than 40μg/L were 100 (inﬁnite LR
+) and 16 %. An inﬁnite positive likelihood ratio indicated that
the probability to be an occasional smoker with a THCCOOH level
greater than 40μg/L was null. Conversely, an LR +of 2.6 associ-
ated with a cut-off of> 3.0μg/L indicated that it was only 2.6
times more likely to be a heavy smoker than an occasional user.
Almost identical results were obtained when considering only
the samples collected after cannabis smoking (results not
shown). Table 3 lists the number of blood specimens that agreed
or disagreed with the condition ‘to be a heavy smoker’ and
fulﬁlled the requirement ‘to be higher than the decision cut-off
of 40 or 3μg THCCOOH/L’.
Discussion
THCCOOH concentrations in WB collected from documented
heavy and occasional cannabis users enrolled in the controlled
administration study are presented. The distinction between
occasional and regular cannabis smokers is important in the
context of driving assessment and evaluation of long-term ﬁtness
to drive. In this respect, Fergusson et al.[22] have shown the
correlation between the rate of active trafﬁc accidents and an
increased frequency of cannabis use. The main ﬁnding of our
study was that the range of THCCOOH levels in the regular
smokers was signiﬁcantly higher than that in the occasional
consumers. We also proposed two thresholds to help distinguish
between regular and occasional cannabis users. According to
Table 1, the two groups of smokers differed mostly in their
frequency of cannabis consumption, with distinct and broad
ranges of use. Because of the large variations in their smoking
habits and inhalation techniques, a broad range of THCCOOH
blood concentrations was expected at inclusion and throughout
the day of the experiment. Although the concentrations varied
considerably, THCCOOH blood levels between occasional and
heavy smokers remained signiﬁcantly different throughout the
day of the experiment, as shown in Figure 1. It is noteworthy that
the experimental conditions included a wide range of
circumstances: blood sampled before smoking or after inhaling
a placebo joint reﬂects what happens in the late elimination
phase, while samples taken during the ﬁrst 3 h following joint
inhalation are typical of the distribution and early elimination
phase. Furthermore, two methods of smoking are represented:
THCCOOH detected at inclusion or after smoking a placebo is
Figure 2. Box and whisker plots (5/95 percentile) comparing the distribution of THCCOOH concentrations in whole blood of occasional and heavy
smokers at different times before and after smoking a cannabis or a placebo joint.
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the result of ad libitum self-administration, while THCCOOH levels
determined after joint smoking are the consequence of the
controlled paced and self-administration. The differences
observed in THCCOOH levels between the occasional and heavy
smokers could therefore be used to establish indicators of the
frequency of cannabis consumption. These differences were also
found to be signiﬁcant when considering each time point
separately (see the box and whisker plots shown in Figure 2).
However, as already mentioned by Toennes et al.,[13] the range
of THCCOOH concentrations partially overlapped between each
group. A grey area was found between about 3.0 and 30 μg/L
for which no sharp distinction could be made. This can be
observed in Figure 2; no signiﬁcant difference could be made
between THCCOOH Cmax in occasional smokers and THCCOOH
concentrations measured in heavy smokers before smoking a
joint or a placebo. Therefore, making a clear distinction between
an occasional consumer who has just smoked a joint and a heavy
smoker who has stopped smoking for several hours is hardly
possible. Daldrup et al.[12] suggested that THCCOOH and THC
levels in serum could be used as indicators to discriminate be-
tween regular and occasional cannabis use. Their conclusions
were that serum THCCOOH concentrations lower than 5μg/L
suggested occasional consumption and levels above 75μg/L
were correlated with regular consumption. These cut-offs were
based on the few published studies that distinguish between
regular and occasional consumers, and which also take into
consideration the eight days between the relevant event and
the time of blood sampling. Depending on whether the driver
with a serum level of 75μg/L stopped or continued to smoke,
his serum concentration eight days before would range between
75 and 150μg/L. When taking into account the blood/
serum-plasma distribution of cannabinoids,[20,21] corresponding
WB concentrations of about 3, 43, and 86μg/L can be calculated.
As shown in Figure 2, this latter value greatly exceeds almost all
of those determined for the group of heavy smokers. Similarly,
the value of 43μg/L exceeds most of the THCCOOH concentra-
tions of the heavy smokers, while the proposed lowest threshold
is in accordance with the majority of the values determined for
the occasional smokers. Furthermore, none of the THCCOOH
concentrations measured in the blood of the occasional smokers
exceeded the threshold value of 43μg/L, while only a few values
determined in the blood of the heavy smokers were lower than
the 3μg/L threshold. Our data were not inconsistent with the
cut-off suggested by Daldrup et al. However, the experimental
conditions of the two studies were signiﬁcantly different.
Regarding their usual consumption of cannabis, we did not ask
the participants to change their habits. However, in the study of
Daldrup et al., the subjects were suspected of driving under the
inﬂuence of cannabis and were asked for further toxicological
investigations within eight days to determine the serum
THCCOOH concentrations. Although the terminal blood half-life
of THCCOOH is very long, it can be assumed (especially if they
were arrested in a time period preceding the terminal elimination
phase) that they would have seriously decreased their consump-
tion, resulting in higher levels of THCCOOH at the time of the
event. Our study evaluates THCCOOH blood levels issues without
exerting any inﬂuence on the smokers’ behaviour. Participants
were even encouraged to keep their habits unchanged and to
maintain their usual cannabis consumption (frequency and dose),
with the exception of abstinence during the four hours prior to
the investigation day.
To determine our cut-off values, we established the ROC
curves. The areas which were close to 1 indicated that heavy
smokers could be clearly distinguished from occasional users.
According to Table 2, if we select 3.0μg/L as a cut-off (Point 2
Figure 3. ROC curves of THCCOOH concentrations in whole blood calcu-
lated (a) before smoking (t = 0 h), (b) after smoking a cannabis joint
(t = 2.5 h) and (c) of THCCOOH values compiled throughout the study. Cir-
cle 1 = 40μg/L: cut-off to rule in heavy smokers. Circle 2 = 3.0μg/L: cut-off
to rule out heav\y smokers.
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of the ROC curve), the speciﬁcity indicated that 62 % of
occasional smokers’ THCCOOH values were correctly assigned
to the occasional group. The sensitivity showed that 97 % of
the heavy users’ samples were higher than 3.0μg/L and were
not falsely attributed to the occasional group. For an unknown
sample with a THCCOOH level of 3.0μg/L, it was 2.6 times more
likely that it belonged to the heavy smokers’ group than to the
occasional smokers. At a concentration of 40μg/L, only 16% of
the heavy smokers’ specimens were correctly detected, but no
samples from the occasional consumers were falsely assigned
(speciﬁcity of 100 %). This is conﬁrmed by the results presented
in Table 3. A null proportion of blood specimens from the
occasional smokers presented a THCCOOH blood concentration
higher than 40μg/L. Consequently, within the context of assess-
ment of ﬁtness to drive, our results suggest 3.0 and 40μg/L as
decision thresholds to assess in which category of cannabis
smokers the drivers belong: occasional (< 3.0μg/L) or heavy
smokers (> 40μg/L)? Our suggested cut-offs are quite similar to
those proposed by Daldrup et al.[12] An external validation of
our decision thresholds was then carried out using the values
reported by Toennes et al.[13] In their study, the authors
compared the serum cannabinoid pharmacokinetic properties
in occasional and heavy users smoking a marijuana or placebo
joint. Figure 4 shows the ROC curve obtained from these serum
data that include 60 heavy smokers’ samples and 22 specimens
from occasional users. The area of the ROC curve (0.7455) was
much lower than that of our study. The sensitivity and speciﬁcity
obtained with these data were 31% and 100 %, respectively, for a
threshold of 70μg/L of serum (corresponding to about 40μg/L in
WB, calculated with the serum-to-WB ratio of 1.75). This conﬁrms
that our proposed cut-off of 40μg/L in WB can be used as a
screening test to detect heavy cannabis users. Concerning the
cut-off of 5μg/L in serum (corresponding to 3μg/L in WB),
Toennes’ values gave a speciﬁcity of 7.1% and a sensitivity of
92 %. However, because very few samples from the occasional
smokers were below this threshold, the positive likelihood ratio
was only 1.0. As mentioned before, there is a paucity of studies
making a clear distinction between occasional and heavy
smokers. Skopp and Pötsch[23] showed that, 24–48 h after their
last drug use, serum THCCOOH levels were below 17μg/L in light
users while heavy, regular users presented a free THCCOOH level
reaching values of 297μg/L. If we consider the THCCOOH
disposition in plasma of frequent cannabis users during
continuous monitored abstinence, the results reported by
Karschner et al.[24] indicate that after 5 days’ abstinence none of
18 long-term heavy cannabis smokers were classiﬁed as heavy
consumers according to our proposed decision threshold of
40μg/L in WB. However, after so long a period of abstinence,
these cannabis users can’t be considered regular consumers
anymore. In daily practice, a large-scale study carried out in all
the main areas of Switzerland has shown that 45% of 6375 blood
specimens collected during the years 2005 to 2007 were above
the decision threshold of 40μg/L. The proportion of cases below
3μg/L was insigniﬁcant (less than 1.5%).[2,25] Furthermore, the
time interval between the trafﬁc event and the blood sampling
was unexpectedly short, with a mean value of 1.5 h
(M. Augsburger, pers. comm.). This short period of time indicates
that a retrospective calculation is generally not required. The
circumstances in which the knowledge of the THCCOOH
Table 2. Diagnostic characteristics of free THCCOOH concentrations test in cannabis smokers enrolled in a joint smoking administration study
THCCOOH blood level THCCOOH estimated serum level* Sensitivity Speciﬁcity Likelihood ratio
Heavy smokers rule out cut-off > 2.5μg/L > 4.4μg/L 98 61 2.5
> 3.0μg/L > 5.2μg/L 97 62 2.6
> 5.0μg/L > 8.7μg/L 91 65 2.6
> 10μg/L > 17μg/L 75 80 3.7
Heavy smokers rule in cut-off > 30μg/L > 52μg/L 29 98 20
> 35μg/L > 61μg/L 23 99 90
> 40μg/L > 70μg/L 16 100 ∞
> 45μg/L > 79μg/L 13 100 ∞
> 50μg/L > 87μg/L 9.5 100 ∞
* Serum/WB ratio = 1.75[20,21]
Table 3. Two by two tables for two different cut-offs (40 and 3.0μg/L).
Number and percentage of blood specimens (total number N=797)
which meet the condition “belong to the heavy smokers’ group” and
THCCOOH level “greater than the cut-off”
Heavy smokers
Yes No
> 40μg/L Yes 66 (8.2 %) 0 (0 %)
No 338 (42.4 %) 393 (49.3 %)
> 3.0μg/L Yes 392 (49.2 %) 152 (19.1 %)
No 12 (1.5 %) 241 (30.2 %)
Figure 4. ROC curve established using values reported in Toennes et al.’s
study[12].
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concentration can be of use are very speciﬁc. The detection of
THC in the blood, within the context of the Swiss zero-tolerance
policy, demonstrates that at the time of blood sampling the
driver was under the inﬂuence of cannabis and his/her ability to
drive was impaired short-term. The forensic expert is then asked
to determine whether their ﬁtness to drive is also altered
long-term. Depending on the clinical and psychological context
of the driver, knowledge of blood THCCOOH levels may be very
useful to guide or narrow diagnosis of chronic use and possibly
of dependence, and facilitate therapeutic follow-up and
treatment. A long and costly therapeutic monitoring will be not
necessary if the THCCOOH level is below 3μg/L and the medical
interview suggests that cannabis smoking is occasional at most.
In this case, the driver can reclaim their driving license. On the
other hand, if the THCCOOH level is higher than 40μg/L and
the medical assessment indicates a regular consumption, a
therapeutic follow-up for a cannabis use disorder must be
undertaken. After a proven period of abstinence and regular
medical follow-ups, a driving license may be returned to a driver
who has been a heavy cannabis smoker in the past. If the
THCCOOH concentration is in the grey zone between 3 and
40μg/L and the medical assessment does not exclude a regular
use, it is advisable to undertake a forensic expertise and a
therapeutic follow-up. Therefore, THCCOOH provides a useful
orientation tool for the forensic expert within the context of
assessing ﬁtness to drive.
Limitations of the study
For each clinical trial, compromises and choices must be made. In
this broad cannabis administration study, two parameters have
greatly inﬂuenced the time-schedule of the day of experiment.
First, we chose to keep the volunteers under close supervision
for several hours before administration of the joint. The second
parameter was the timing of the fMRI sessions. Finally, the
infrastructure of the clinical research centre, the ethical
committee agreement, and the volunteers’ availability were not
compatible with a multi-day experiment. The drawback was that
a long investigation after inhalation was not possible. The robust-
ness of the proposed cut-offs should be tested in a variety of
conditions. Other ways of smoking and different dosage
regimens should be investigated. The inﬂuence of varying the
proportions of tobacco should also be tested. Furthermore,
different frequencies of consumption could be considered, for
instance regular versus intermittent versus ‘weekend binge weed
smoking’. In addition, the concurrent intake of illegal or therapeu-
tic drugs interacting with THC metabolism could be studied. The
consequences of altered THC metabolism related to genetic poly-
morphisms of CYP2C9 and glucuronosyltransferase enzymes
should also be evaluated. In our opinion, it could be interesting
to quantify separately free THCCOOH and its glucuronide
conjugate. However, this molecule is almost never considered
in routine work.
Conclusion
Whole blood THCCOOH concentrations of heavy cannabis smokers
determined in a controlled administration study greatly exceeded
those measured in the occasional users’ group. Therefore, we can
take advantage of this difference to estimate to which category
of smokers the drivers belong. A level of THCCOOH higher than
40μg/L is strongly correlated with a heavy consumption of canna-
bis, whereas a concentration below 3μg/L suggests occasional use.
These threshold values can be used as guidance criteria to help the
forensic expert in the classiﬁcation of impaired drivers as heavy or
occasional users. A heavy consumption may suggest a long-term
unﬁtness to drive that should be followed by further toxicological
investigations and therapeutic follow-up. Once abstinence has
been demonstrated, the driver can reclaim their driving license.
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